Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules CapitalBusiness Wire • 09/11/23
Senseonics Holdings (SENS) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/11/23
Senseonics Holdings, Inc. Schedules Second Quarter 2023 Earnings Release and Conference Call for August 10, 2023 at 4:30 p.m. Eastern TimeBusiness Wire • 07/27/23
New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific SessionsBusiness Wire • 06/26/23
Senseonics shares jump 6.7% on new insurance coverage for continuous glucose monitorMarket Watch • 06/02/23
Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with DiabetesBusiness Wire • 06/02/23
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/23
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEMPRNewsWire • 05/09/23
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern TimeBusiness Wire • 04/27/23
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOKPRNewsWire • 04/24/23